An oral Covid-19 pill developed by the American drugmaker Merck has been found to significantly reduce the risk of death and hospitalization in patients participating in a new clinical trial, according to the company’s data. The company, which is developing the drug in partnership with Ridgeback Biotherapeutics, reported that molnupiravir “reduced the risk of hospitalization […]
